LENZ Therapeutics, Inc. (LENZ)
LENZ Stock Price Chart
Explore LENZ Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze LENZ price movements and trends.
LENZ Company Profile
Discover essential business fundamentals and corporate details for LENZ Therapeutics, Inc. (LENZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Mar 2024
Employees
6.00
Website
https://www.lenz-tx.comCEO
Evert B. Schimmelpennink
Description
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
LENZ Financial Timeline
Browse a chronological timeline of LENZ Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Nov 2025
EPS estimate is -$0.67.
Earnings released on 30 Jul 2025
EPS came in at -$0.53 surpassing the estimated -$0.58 by +8.62%, while revenue for the quarter reached $5.00M , beating expectations by +600.00%.
Earnings released on 7 May 2025
EPS came in at -$0.53 surpassing the estimated -$0.55 by +3.64%.
Earnings released on 19 Mar 2025
EPS came in at -$0.46 falling short of the estimated -$0.42 by -9.52%.
Earnings released on 6 Nov 2024
EPS came in at -$0.38 surpassing the estimated -$0.47 by +19.15%.
Earnings released on 14 Aug 2024
EPS came in at -$0.40 surpassing the estimated -$0.49 by +18.37%.
Earnings released on 8 May 2024
EPS came in at -$3.53 falling short of the estimated -$0.84 by -320.24%.
Dividend declared on 22 Mar 2024
A dividend of $1.03 per share was announced, adjusted to $7.21.
Stock split effective on 22 Mar 2024
Shares were split 1 : 7 , changing the number of shares outstanding and the price per share accordingly.
Dividend declared on 15 Mar 2024
A dividend of $1.03 per share was announced, adjusted to $7.21.
Earnings released on 27 Feb 2024
EPS came in at -$0.40 falling short of the estimated -$0.13 by -207.69%.
Earnings released on 13 Nov 2023
EPS came in at -$0.19 surpassing the estimated -$0.25 by +24.00%.
Earnings released on 29 Jun 2023
EPS came in at -$6.82 falling short of the estimated -$6.79 by -0.49%.
Earnings released on 30 Mar 2023
EPS came in at -$3.00 falling short of the estimated -$2.41 by -24.54%.
Earnings released on 30 Dec 2022
EPS came in at -$3.09 surpassing the estimated -$3.45 by +10.54%.
Earnings released on 29 Sept 2022
EPS came in at -$3.13 falling short of the estimated -$3.11 by -0.63%.
Earnings released on 29 Jun 2022
EPS came in at -$3.42 surpassing the estimated -$3.44 by +0.57%.
Earnings released on 30 Mar 2022
EPS came in at -$3.39 .
Earnings released on 30 Dec 2021
EPS came in at -$2.28 surpassing the estimated -$2.73 by +16.33%.
Earnings released on 29 Sept 2021
EPS came in at -$1.76 .
Earnings released on 29 Jun 2021
EPS came in at -$2.19 .
Earnings released on 31 Mar 2021
EPS came in at -$2.38 .
Earnings released on 31 Dec 2020
EPS came in at -$7.66 .
Earnings released on 30 Sept 2020
EPS came in at -$0.41 .
LENZ Stock Performance
Access detailed LENZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.